QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals;
QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee...
top of page
Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies
Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk...
NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced it has submitted a 510(k) premarket notification to the ...
Press
bottom of page